Detalles de la búsqueda
1.
Apoptosis reprogramming triggered by splicing inhibitors sensitizes multiple myeloma cells to Venetoclax treatment.
Haematologica
; 107(6): 1410-1426, 2022 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34670358
2.
Pre-transplant minimal residual disease assessment and transplant-related factors predict the outcome of acute myeloid leukemia patients undergoing allogeneic stem cell transplantation.
Eur J Haematol
; 107(5): 573-582, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34297437
3.
The new small tyrosine kinase inhibitor ARQ531 targets acute myeloid leukemia cells by disrupting multiple tumor-addicted programs.
Haematologica
; 105(10): 2420-2431, 2020 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33054082
4.
National Italian Delphi panel consensus: which measures are indicated to minimize pegylated-asparaginase associated toxicity during treatment of adult acute lymphoblastic leukemia?
BMC Cancer
; 20(1): 956, 2020 Oct 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33008391
5.
Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma. A CAMPUS ALL study.
Am J Hematol
; 95(12): 1466-1472, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32777149
6.
Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells' vulnerability to DNA-damaging agents.
Haematologica
; 103(1): 80-90, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29025907
7.
Real-world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts.
Am J Hematol
; 98(8): E204-E208, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37222267
8.
Performance of serum (1,3)-ß-d-glucan screening for the diagnosis of invasive aspergillosis in neutropenic patients with haematological malignancies.
Mycoses
; 61(9): 650-655, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-29693758
9.
Good tolerability of high dose colistin-based therapy in patients with haematological malignancies.
Infection
; 45(4): 505-511, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28353153
10.
High feasibility and antileukemic efficacy of fludarabine, cytarabine, and idarubicin (FLAI) induction followed by risk-oriented consolidation: A critical review of a 10-year, single-center experience in younger, non M3 AML patients.
Am J Hematol
; 91(8): 755-62, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27084986
11.
Blastic Plasmacytoid Dendritic Cell Neoplasm: Underlining the importance of an early diagnosis and the use of tagraxofusp therapy before wide dissemination.
Australas J Dermatol
; 62(2): e316-e318, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32757292
12.
Longitudinal minimal residual disease (MRD) evaluation in acute myeloid leukaemia with NPM1 mutation: from definition of molecular relapse to MRD-driven salvage approach.
Br J Haematol
; 186(6): e223-e225, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31348524
13.
Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information.
Br J Haematol
; 184(3): 457-460, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29359798
14.
Liposomal daunorubicin, fludarabine, and cytarabine (FLAD) as bridge therapy to stem cell transplant in relapsed and refractory acute leukemia.
Ann Hematol
; 93(12): 2011-8, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24989345
15.
Prompt detection of L-asparaginase inactivation is crucial to optimize treatment efficacy also in aggressive lymphomas.
Hematol Oncol
; 36(2): 498-499, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29052244
16.
De novo AML patients with favourable-intermediate karyotype may benefit from the addition of low-dose gemtuzumab ozogamicin (GO) to fludarabine, Ara-C and idarubicin (FLAI): a contribution to the reopened "GO question".
Ann Hematol
; 92(10): 1309-18, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23686116
17.
A blastic plasmacytoid dendritic cell neoplasm-like phenotype identifies a subgroup of npm1-mutated acute myeloid leukemia patients with worse prognosis.
Am J Hematol
; 93(2): E33-E35, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29080220
18.
Donor selection for adoptive immunotherapy with NK cells in AML patients: Comparison between analysis of lytic NK cell clones and phenotypical identification of alloreactive NK cell repertoire.
Front Immunol
; 14: 1111419, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36865545
19.
Harnessing Immune Response in Acute Myeloid Leukemia.
J Clin Med
; 12(18)2023 Sep 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37762763
20.
Multicenter Observational Retrospective Study on Febrile Events in Patients with Acute Myeloid Leukemia Treated with Cpx-351 in "Real-Life": The SEIFEM Experience.
Cancers (Basel)
; 15(13)2023 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37444567